Stifel lowers SPS Commerce stock price target to $150 on macro concerns

SPS Commerce (SPSC) reported strong Q2 2025 results, surpassing analyst expectations for both EPS and revenue, yet faces mixed analyst sentiment. Stifel reduced its price target to $150 from $165 while maintaining a Buy rating, citing insights from an analyst day, while DA Davidson and Loop Capital downgraded the stock. This divergence, occurring as SPSC trades near its 52-week low, reflects broader concerns over future growth outlooks and macroeconomic softness despite management's confidence in achieving high-single-digit revenue growth and 200 basis points of annual adjusted EBITDA margin expansion.

Analysis

SPS Commerce (SPSC) presents a significant divergence between strong current financial performance and cautious forward-looking analyst sentiment. The company surpassed Q2 2025 expectations with an EPS of $1.00 versus a $0.91 forecast and revenue of $187.4 million against a $185.82 million estimate. Despite these beats and upward earnings estimate revisions from five analysts, SPSC's stock is trading near its 52-week low. This price action reflects multiple recent analyst downgrades; DA Davidson moved to Neutral and Loop Capital to Hold, both citing a revised, more moderate growth outlook beyond 2025. In contrast, Stifel maintained its Buy rating but reduced its price target to $150 from $165, expressing confidence in management's ability to deliver high-single-digit revenue growth and 200 basis points of annual adjusted EBITDA margin expansion. The market appears to be weighing concerns over future macroeconomic softness and potential tariff impacts, as noted by Needham, more heavily than the company's recent outperformance and management's optimistic commentary from its analyst day.

Key Decisions for Investors

• Investors with a higher risk tolerance might consider the current share price near a 52-week low a potential entry point, banking on management's ability to achieve its stated growth and margin expansion targets despite market skepticism.
• Cautious investors should closely monitor upcoming Q3 and Q4 results for confirmation of the 'nascent revenue recovery' and management's effectiveness in navigating the highlighted macroeconomic softness before committing capital.
• Portfolio managers should weigh the conflicting signals of strong trailing results and upward earnings revisions against the series of analyst downgrades, which suggests a potential deceleration in the long-term growth narrative.